Exhibitor Category: Bronze Sponsor

ARCT-032 is an inhaled investigational mRNA therapeutic designed to express normal functional CFTR in the lungs of individuals with CF. ARCT-032 utilizes Arcturus’ LUNAR® lipid-mediated aerosolized platform to deliver CFTR messenger RNA to the lungs. Expression of a functional copy of the CFTR mRNA in the lungs of people with CF has the potential to

Baxter is a global medtech leader, providing connected devices, medicines and technologies that healthcare providers use to enable the best patient care possible, while streamlining workflows for the care team. We work alongside care teams to connect the dots across the patient journey – using the latest technologies to help our customers meet their biggest

NEILMED® CORE VALUES To improve the personal health of individuals worldwide while building a legendary company and culture. – Persistence: We take a positive, can-do attitude to get things done, no matter the obstacles. – Risk-Taking: We take calculated risks as entrepreneurs to accelerate business growth. – Improve Quality: We continuously work to strengthen and

The Cystic Fibrosis Engagement Network (CFEN) serves as a central voice of patients advocating for policies that further patient access to approved CF therapies. In so doing, CFEN seeks to serve as a leading educational and advocacy organization focused on policy matters impacting CF patient access to optimal care.

4DMT is a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. The Company’s lead product candidate 4D-150 is designed to be a backbone therapy forming the foundation of treatment of blinding retinal vascular diseases by providing multi-year sustained delivery of anti-VEGF (aflibercept

Walgreens Specialty Pharmacy provides care for patients with complex, chronic, or rare conditions requiring specialized medications and support. They offer a range of services, including medication management, financial assistance coordination, and clinical support, with a focus on enhancing patient experience and adherence. The specialty pharmacy leverages trained pharmacists and nurses with expertise in specific disease

Clarametyx Biosciences is a Columbus, Ohio-based company developing therapies and vaccines targeting the biofilm—a protective layer around bacteria— to treat chronic and recalcitrant respiratory infections. This innovative technology platform aims to disrupt biofilms to reduce biofilm-related inflammation and enable more effective immune responses and antibiotic interventions. Our first program, CMTX-101, is in a Phase 2

Digestive Care, Inc. (DCI) is dedicated to developing unique pharmaceutical products to alleviate complications and symptoms of gastrointestinal disorders. DCI’s flagship product, PERTZYE® (pancrelipase) is a unique formulation of enteric-coated microspheres containing pancreatic enzymes buffered with bicarbonate, designed to simulate normal pancreatic function and create a pH microenvironment for optimized biological activity of the enzymes